Cancer Familial Aggregation (CFA) and G446A polymorphism in ARLTS1 gene

Breast Cancer Research and Treatment

Volumn 99, Issue 1, 2006, Pages 59-62

  Masojć, Bartłomiej ^a   Mierzejewski, Marek ^a   Cybulski, Cezary ^a   Van De Wetering, Thierry ^a   Dȩbniak, Tadeusz ^a   Górski, Bohdan ^a   Jaworowska, Ewa ^a   Tarnowska, Czesława ^a   Lenner, Marcin ^a   Scott, Rodney J ^b   Lubiński, Jan ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

ARLTS1 gene; Breast cancer; Cancer Familial Aggregation; CFA; G446A; Laryngeal cancer; Melanoma malignum; Polymorphism; Prostate cancer; Thyroid papillary cancer; Trp149Stop; Tumor suppressor

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSE;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR LIKE TUMOR SUPPRESSOR 1 GENE; ADULT; ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER FAMILY; CANCER PATIENT; COMPARATIVE STUDY; CONTROLLED STUDY; FAMILIAL CANCER; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GERM LINE; HUMAN; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; PROSTATE CANCER; STATISTICAL SIGNIFICANCE; THYROID PAPILLARY CARCINOMA; TUMOR SUPPRESSOR GENE;

ADP-RIBOSYLATION FACTORS; ALLELES; BREAST NEOPLASMS; FAMILY HEALTH; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MELANOMA; NEOPLASMS; ODDS RATIO; POLYMORPHISM, GENETIC;

EID: 33746778847     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-006-9180-5     Document Type: Article

References (15)

1. Liede A, Karlan BY, Narod SA: Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature. J Clin Oncol 22(4): 735-742, 2004
2. Watson P, Lynch HT: Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 71: 677-685, 1993
3. Calin GA, Trapasso F, Shimizu M, Dumitru CD, Yendamuri S, Godwin AK, Ferracin M, Bernardi G, Chatterjee D, Baldassarre G, Rattan S, Alder H, Mabuchi H, Shiraishi T, Hansen LL, Overgaard J, Herlea V, Mauro FR, Dighiero G, Movsas B, Rassenti L, Kipps T, Baffa R, Fusco A, Mori M, Russo G, Liu CG, Neuberg D, Bullrich F, Negrini M, Croce CM: Familial cancer associated with a polymorphism in ARLTS1. N Engl J Med 352(16): 1667-1676, 2005
4. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215, 1988
5. Debniak T, Scott RJ, Huzarski T, Byrski T, Rozmiarek A, Debniak B, Zaluga E, Maleszka R, Kladny J, Gorski B, Cybulski C, Gronwald J, Kurzawski G, Lubinski J: CDKN2A common variants and their association with melanoma risk: a population-based study. Cancer Res 65(3): 835-839, 2005
6. Gorski B, Jakubowska A, Huzarski T, Byrski T, Gronwald J, Grzybowska E, Mackiewicz A, Stawicka M, Bebenek M, Sorokin D, Fiszer-Maliszewska L, Haus O, Janiszewska H, Niepsuj S, Gozdz S, Zaremba L, Posmyk M, Pluzanska M, Kilar E, Czudowska D, Wasko B, Miturski R, Kowalczyk JR, Urbanski K, Szwiec M, Koc J, Debniak B, Rozmiarek A, Debniak T, Cybulski C, Kowalska E, Toloczko-Grabarek A, Zajaczek S, Menkiszak J, Medrek K, Masojc B, Mierzejewski M, Narod SA, Lubinski J: A high proportion of founder BRCA1 mutations in Polish breast cancer families. Int J Cancer 110: 683-686, 2004
7. Cybulski C, Huzarski T, Gorski B, Masojc B, Mierzejewski M, Debniak T, Gliniewicz B, Matyjasik J, Zlowocka E, Kurzawski G, Sikorski A, Posmyk M, Szwiec M, Czajka R, Narod SA, Lubinski J: A novel founder CHEK2 mutation is associated with increased prostate cancer risk. Cancer Res 64: 2677-2679, 2004
8. Hemminki K, Eng C: Clinical genetic counselling for familial cancers requires reliable data on familial cancer risks and general action plans. J Med Genet 41(11): 801-807, 2004 Review
9. Bermejo JL, Hemminki K: Familial risk of cancer shortly after diagnosis of the first familial tumor. J Natl Cancer Inst 97(21): 1575-1579, 2005
10. Cybulski C, Gorski B, Huzarski T, Masojc B, Mierzejewski M, Debniak T, Teodorczyk U, Byrski T, Gronwald J, Matyjasik J, Zlowocka E, Lenner M, Grabowska E, Nej K, Castaneda J, Medrek K, Szymanska A, Szymanska J, Kurzawski G, Suchy J, Oszurek O, Witek A, Narod SA, Lubinski J: CHEK2 is a multiorgan cancer susceptibility gene. Am J Hum Genet 75(6): 1131-1135, 2004 Epub 2004 Oct 18.
11. Meijers-Heijboer H, Wijnen J, Vasen H, Wasielewski M, Wagner A, Hollestelle A, Elstrodt F, van den Bos R , de Snoo A , Fat GT, Brekelmans C, Jagmohan S, Franken P, Verkuijlen P, van den Ouweland A , Chapman P, Tops C, Moslein G, Burn J, Lynch H, Klijn J, Fodde R, Schutte M: The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype. Am J Hum Genet 72(5): 1308-1314, 2003 Epub 2003 Apr 10
12. Begg CB, Orlow I, Hummer AJ, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Mitra N, Busam K, From L, Berwick M: Genes Environment and Melanoma Study Group. Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample. J Natl Cancer Inst 97(20): 1507-1515, 2005
13. Goldstein AM: Familial melanoma, pancreatic cancer and germline CDKN2A mutations. Hum Mutat 23 (6): 630, 2004
14. Debniak T, Gorski B, Huzarski T, Byrski T, Cybulski C, Mackiewicz A, Gozdecka-Grodecka S, Gronwald J, Kowalska E, Haus O, Grzybowska E, Stawicka M, Swiec M, Urbanski K, Niepsuj S, Wasko B, Gozdz S, Wandzel P, Szczylik C, Surdyka D, Rozmiarek A, Zambrano O, Posmyk M, Narod SA, Lubinski J: A common variant of CDKN2A (p16) predisposes to breast cancer. J Med Genet 42(10): 763-765, 2005 Epub 2005 May 6
15. Frank B, Klaes R, Burwinkel B: Familial cancer and ARLTS1. N Engl J Med. 353(3): 313-314, 2005 author reply 313-4